Today on Biotech Buzz we have Tassos Gianakakos, who founded three companies and is now CEO of MyoKardia, a drug discovery company that develops innovative therapeutics to treat genetic heart disease.

 

Tassos is an entrepreneur and a leader in the biopharmaceutical industry, he is working to find cures for conditions that affect 60 million people worldwide, including one million in the United States.

 

Tune into hear the interview!